SCHEDULE: Gates Capital Discloses 5.9% Stake in Neogen

Gates Capital Management and its affiliates have disclosed a passive 5.9% beneficial ownership stake in Neogen Corporation's common stock.

Summary

• Gates Capital Management, L.P., along with its general partner, managing member, and President Jeffrey L. Gates, collectively reported beneficial ownership of 12,793,941 shares of Neogen Corporation's Common Stock.
• This represents 5.9% of Neogen Corporation's outstanding Common Stock.
• The calculation is based on 217,205,186 shares outstanding as of June 30, 2025, as reported in Neogen's Form 10-K filed on July 30, 2025.
• The reporting persons hold shared voting and shared dispositive power over all 12,793,941 shares.
• The acquisition of these securities was in the ordinary course of business and not for the purpose of changing or influencing control of Neogen Corporation.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive stake by a reputable investment firm is generally a positive signal, indicating confidence in the company's value, even if it's not an active investment.

Positives

• A significant institutional investor, Gates Capital Management, has taken a substantial passive stake, potentially indicating confidence in Neogen's long-term prospects.
• The investment is stated to be in the ordinary course of business, suggesting a strategic portfolio allocation rather than an activist intent.

Future Outlook

This filing is a disclosure of current ownership and does not contain forward-looking statements or guidance regarding Neogen Corporation's future performance or the reporting persons' future investment intentions beyond the passive nature of the stake.

Management Comments

• The filing includes a certification by Jeffrey L. Gates stating that the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of the issuer.

Industry Context

This filing indicates a significant passive investment by a major capital management firm in Neogen Corporation, a company operating in the animal health and food safety sectors. Such institutional investments can signal market confidence in the long-term growth prospects of companies within these essential industries, which are often characterized by stable demand and regulatory drivers.

Comparison to Industry Standards

• As a Schedule 13G filing, this document primarily discloses a passive ownership stake and does not provide operational or financial results for comparison. Therefore, direct comparisons to industry-specific performance benchmarks or competitor results are not applicable within the scope of this filing.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor's stake may be viewed positively, potentially increasing investor confidence and liquidity.
• Management: Awareness of a large passive shareholder may influence strategic decisions, though the filing explicitly states no intent to influence control.

Next Steps

• The reporting persons will continue to monitor their investment in Neogen Corporation. Future filings (e.g., Schedule 13D if intent changes, or subsequent 13G amendments for significant changes in ownership) would be required if their beneficial ownership percentage changes significantly or their investment intent shifts from passive.

Key Dates

Recommendation

This filing is a disclosure of a passive ownership stake by an institutional investor, not an operational or financial report from Neogen Corporation itself. While the presence of a significant institutional investor like Gates Capital Management can be seen as a positive signal of confidence in Neogen's long-term value, the filing provides no new fundamental information about Neogen's business performance, financial health, or strategic direction that would warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and await Neogen's own financial reports for actionable insights.

Keywords

Neogen Corporation, Gates Capital Management, Institutional Ownership, Common Stock, SEC Filing, Schedule 13G, Beneficial Ownership, Investment Management, Animal Health, Food Safety